Uses and limitations of randomization-based efficacy estimators
From MaRDI portal
Publication:5424959
DOI10.1191/0962280205SM406OAzbMath1122.62376OpenAlexW2074501218WikidataQ81247869 ScholiaQ81247869MaRDI QIDQ5424959
Publication date: 7 November 2007
Published in: Statistical Methods in Medical Research (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1191/0962280205sm406oa
Applications of statistics to biology and medical sciences; meta analysis (62P10) Estimation in survival analysis and censored data (62N02)
Related Items (3)
A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments ⋮ A Comparison of Methods for Estimating the Causal Effect of a Treatment in Randomized Clinical Trials Subject to Noncompliance ⋮ Instrumental variable estimation of early treatment effect in randomized screening trials
Uses Software
Cites Work
- Correcting for non-compliance in randomized trials using rank preserving structural failure time models
- Bayesian inference for causal effects in randomized experiments with noncompliance
- Semiparametric instrumental variable estimation of treatment response models.
- Principal Stratification in Causal Inference
- A Causal Proportional Hazards Estimator for the Effect of Treatment Actually Received in a Randomized Trial with All-or-Nothing Compliance
- Some Surprising Results about Covariate Adjustment in Logistic Regression Models
- Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes
- A geometric approach to assess bias due to omitted covariates in generalized linear models
- Estimating Outcome Distributions for Compliers in Instrumental Variables Models
- Assessing the effect of an influenza vaccine in an encouragement design
- Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests
- Correcting for non-compliance in randomized trials using structural nested mean models
This page was built for publication: Uses and limitations of randomization-based efficacy estimators
